MedTrace Logo

Rapid Screening Test for Covid-19 Antibodies in Healthcare Workers

NCT04525417 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2021-02-03

No results posted yet for this study

Summary

The study objectives were to assess 1/the immune status of healthcare professionals with suggestive symptomatology of Covid-19 infection and 2/the sensitivity and specificity of AAZ rapid test by comparing it with a serological ELISA test.

An open-label, monocentric, prospective, non-randomized study, is conducted, including 50 hospital healthcare professionals and 50 private health professionals.

Knowledge of serostatus will achieve the implementation of a strategy of management of patients according to specific immunity of health professionals

Conditions

  • Covid-19 Immune Status of Healthcare Workers

Interventions

DIAGNOSTIC_TEST

AAZ Covid-19 rapid test

To assess the immune status

Sponsors & Collaborators

  • Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux

    lead NETWORK

Principal Investigators

  • Elisabeth Bouvet, MD · Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-25
Primary Completion
2020-09-25
Completion
2020-10-25

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04525417 on ClinicalTrials.gov